| pubmed-article:17805064 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C1516224 | lld:lifeskim |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C0935989 | lld:lifeskim |
| pubmed-article:17805064 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17805064 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:17805064 | pubmed:dateCreated | 2007-9-6 | lld:pubmed |
| pubmed-article:17805064 | pubmed:abstractText | The tyrosine kinase KIT has variable expression in small-cell lung cancer (SCLC) and may be a prognostic factor. Imatinib targets KIT expression, providing rationale for studying its role in combination with chemotherapy in SCLC in a multicenter phase II trial. | lld:pubmed |
| pubmed-article:17805064 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17805064 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17805064 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17805064 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17805064 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:HainsworthJoh... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:GrecoF... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:BurrisHoward... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:SpigelDavid... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:MallidiPadmaj... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:YardleyDenise... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:Minnie... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:MengChristina... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:SimonsLisaL | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:GrapskiRichar... | lld:pubmed |
| pubmed-article:17805064 | pubmed:author | pubmed-author:SchreederMars... | lld:pubmed |
| pubmed-article:17805064 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17805064 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:17805064 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17805064 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17805064 | pubmed:pagination | 854-61 | lld:pubmed |
| pubmed-article:17805064 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:meshHeading | pubmed-meshheading:17805064... | lld:pubmed |
| pubmed-article:17805064 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17805064 | pubmed:articleTitle | Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. | lld:pubmed |
| pubmed-article:17805064 | pubmed:affiliation | Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, Tennessee 37203, USA. | lld:pubmed |
| pubmed-article:17805064 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17805064 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17805064 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17805064 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17805064 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17805064 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17805064 | lld:pubmed |
